Intest Res.  2018 Apr;16(2):315-318. 10.5217/ir.2018.16.2.315.

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience

• Park J
• Cheon JH
• Park Y
• Park SJ
• Kim TI
• Kim WH

• KMID: 2417686
• DOI: http://doi.org/10.5217/ir.2018.16.2.315

Abstract

No abstract available.

MeSH Terms

Methotrexate*
Methotrexate

Figure

• 

  Fig. 1 (A) Serial changes in CRP level and (B) ESR at 3 and 6 months after the initiation of methotrexate treatment in patients with refractory intestinal Behçet's disease.

Reference

1. Kim JH, Cheon JH, Kim WH. The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease. Korean J Gastroenterol. 2008; 51:291–297. PMID: 18516013.

2. Khanna R, Feagan BG. Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events. Expert Opin Drug Saf. 2015; 14:987–997. PMID: 25819509.

3. Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet's disease: a review. World J Gastroenterol. 2015; 21:3801–3812. PMID: 25852265.

4. Cheon JH, Han DS, Park JY, et al. Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet's disease. Inflamm Bowel Dis. 2011; 17:605–613. PMID: 20848515.

5. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989; 110:353–356. PMID: 2492786.

6. Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis. 2003; 35:619–627. PMID: 14563183.

7. Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R. 6-Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2000; 12:1227–1233. PMID: 11111780.

8. Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behçet's disease. Curr Opin Rheumatol. 2015; 27:24–31. PMID: 25405821.

9. Feagan BG, McDonald JW, Panaccione R, et al. Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease. Gastroenterology. 2014; 146:681–688.e1. PMID: 24269926.